The North America bioinformatics market is expected to grow from US$ 6,429.54 million in 2022 to US$ 15,559.78 million by 2028; it is estimated to grow at a CAGR of 15.9% from 2022 to 2028.

Increased Number of Genomic Research Activities with Corresponding Adoption of Bioinformatics Drives Market Growth

In the field of genetics and genomics, the bioinformatics aids in sequencing and annotating genomes. Bioinformatics plays a major role in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data, generally in the understanding of evolutionary aspects of molecular biology. The role of human genomics research and related biotechnologies has the potential to achieve several public health goals, such as reducing health inequalities by providing countries with efficient, cost-effective, and robust means of preventing, diagnosing, and treating major diseases, such as cancer, that burden their populations. The initiatives to generate and collect human genomic data are rapidly increasing across multiple countries. Thus, the increasing number of genomics activities, along with the rising adoption of bioinformatics, is driving the bioinformatics market across the region.

Market Overview

The North America bioinformatics market is segmented into the US, Canada, and Mexico. The US held the largest share of the North America bioinformatics market in 2022. The market growth is due to growing healthcare and research expenditure, an increasing number of pharmaceutical and biopharmaceutical companies, and a surge in government support to enhance research and academic institutes. According to US Centers for Medicare & Medicaid Services, the national healthcare expenditure in the US increased reached US$ 4.1 trillion in 2020, registering an increase of 9.7% from 2019 to 2020. The national health spending is expected to grow at a 5.4% annual rate from 2019 to 2028, and it is expected to reach US$6.2 trillion by 2028. The US government initiated various research programs to boost the genomic research, including the ‘All of Us Research Program’ led by NIH, which provided US$ 28.6 million in funding to develop three genome centers across the US. This research program will accelerate precision medicine discoveries through bioinformatics services in different institutions in the US. Further, rapid healthcare expenditure growth results in the launch of diagnostic tools for the evaluation of various genetic diseases and cancer studies for potential medical treatments. Similarly, the pharmaceutical & biopharmaceutical industry’s growth is significantly contributing to the US bioinformatics market growth. As a result, the industry expansion accelerates the growth of the development and commercialization of pharmaceutical and biopharmaceutical products. The market players in the country received various patents for their innovations. Thus, the growing bioinformatics services and launch of products for various genetic diseases and cancer studies in the pharmaceutical & biopharmaceutical industries will boost the bioinformatics market growth.

North America Bioinformatics Market Revenue and Forecast to 2028 (US$ Million)

North America Bioinformatics Market Segmentation

The North America bioinformatics market is segmented on the basis of product, application, sector, and country.

Based on product, the North America bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held the largest market share in 2022. Based on application, the North America bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2022. Based on sector, the North America bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest market share in 2022. Based on country, the North America bioinformatics market is categorized into the US, Canada, and Mexico. Further, the US dominated the market in 2022. Agilent Technologies, Inc.; Biomax Informatics AG; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. are the leading companies operating in the North America bioinformatics market.

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
1.2.1 North America Bioinformatics Market – By Product
1.2.2 North America Bioinformatics Market – By Application
1.2.3 North America Bioinformatics Market – By Sector
1.2.4 North America Bioinformatics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioinformatics Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Bioinformatics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Funding and Investments in Bioinformatics
5.1.2 Increased Number of Genomic Research Activities with Corresponding Adoption of Bioinformatics
5.2 Market Restraint
5.2.1 Lack of Interoperability and Multiplatform Capabilities
5.3 Market Opportunities
5.3.1 Rising Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Integration of Artificial Intelligence (AI) and Machine Learning in Bioinformatics
5.5 Impact Analysis
6. Bioinformatics Market – North America Analysis
6.1 North America Bioinformatics Market Revenue Forecast & Analysis
7. North America Bioinformatics Market Analysis – By Product
7.1 Overview
7.2 North America Bioinformatics Market Revenue Share by Product (2022 and 2028)
7.3 Bioinformatics Platforms
7.3.1 Overview
7.3.2 Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Knowledge Management Tools
7.4.1 Overview
7.4.2 Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
7.5 Bioinformative Services
7.5.1 Overview
7.5.2 Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8. North America Bioinformatics Market Analysis – By Application
8.1 Overview
8.2 North America Bioinformatics Market Revenue Share, by Application (2022 and 2028)
8.3 Genomics
8.3.1 Overview
8.3.2 Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Proteomics
8.4.1 Overview
8.4.2 Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.5 ChemoInformatics and Drug Design
8.5.1 Overview
8.5.2 ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.6 Transcriptomics
8.6.1 Overview
8.6.2 Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.7 Metabolomics
8.7.1 Overview
8.7.2 Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
9. North America Bioinformatics Market Analysis – By Sector
9.1 Overview
9.2 North America Bioinformatics Market Share, by Sector, 2022 and 2028, (%)
9.3 Medical Biotechnology
9.3.1 Overview
9.3.2 Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Animal Biotechnology
9.4.1 Overview
9.4.2 Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.5 Agricultural Biotechnology
9.5.1 Overview
9.5.2 Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Academics
9.6.1 Overview
9.6.2 Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
9.7 Environmental Biotechnology
9.7.1 Overview
9.7.2 Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.8 Forensic Biotechnology
9.8.1 Overview
9.8.2 Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
10. North America Bioinformatics Market – Country Analysis
10.1 North America: Bioinformatics Market
10.1.1 Overview
10.1.2 North America: Bioinformatics Market, by Country, 2022 & 2028 (%)
10.1.2.1 US: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 US: Bioinformatics Market, by Product, 2019–2028 (US$ Million)
10.1.2.1.4 US: Bioinformatics Market, by Application, 2019–2028 (US$ Million)
10.1.2.1.5 US: Bioinformatics Market, by Sector, 2019–2028 (US$ Million)
10.1.2.2 Canada: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Canada: Bioinformatics Market, by Product, 2019–2028 (US$ Million)
10.1.2.2.4 Canada: Bioinformatics Market, by Application, 2019–2028 (US$ Million)
10.1.2.2.5 Canada: Bioinformatics Market, by Sector, 2019–2028 (US$ Million)
10.1.2.3 Mexico: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Mexico: Bioinformatics Market, by Product, 2019–2028 (US$ Million)
10.1.2.3.4 Mexico: Bioinformatics Market, by Application, 2019–2028 (US$ Million)
10.1.2.3.5 Mexico: Bioinformatics Market, by Sector, 2019–2028 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. COMPANY PROFILES
12.1 Dassault Systèmes
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bruker Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Agilent Technologies, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Eurofins Scientific
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Illumina, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PerkinElmer Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 QIAGEN
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Thermo Fisher Scientific Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Biomax Informatics AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Bioinformatics Market – Revenue and Forecast to 2028 (US$ Mn)
Table 2. US Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Bioinformatics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 4. US Bioinformatics Market, by Sector – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Bioinformatics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Bioinformatics Market, by Sector– Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Bioinformatics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Bioinformatics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Bioinformatics Market, by Sector– Revenue and Forecast to 2028 (US$ Million)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Bioinformatics Market Segmentation
Figure 2. North America Bioinformatics Segmentation, by Country
Figure 3. North America Bioinformatics Market Overview
Figure 4. North America Bioinformatics Market, By Product
Figure 5. North America Bioinformatics Market, By Country
Figure 6. North America PEST Analysis
Figure 7. North America Bioinformatics Market Impact Analysis of Drivers and Restraints
Figure 8. North America Bioinformatics Market – Revenue Forecast and Analysis
Figure 9. North America Bioinformatics Market Revenue Share by Product (2022 and 2028)
Figure 10. North America Bioinformatics Platforms: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 11. North America Knowledge Management Tools: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 12. North America Bioinformative Services: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 13. North America Bioinformatics Market Revenue Share, by Application (2022 and 2028)
Figure 14. North America Genomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 15. North America Proteomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 16. North America ChemoInformatics and Drug Design: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 17. North America Transcriptomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 18. North America Metabolomics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 19. North America Others: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. North America Bioinformatics Market Share, by Sector, 2022 and 2028 (%)
Figure 21. North America Medical Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Animal Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Agricultural Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Academics: Bioinformatics Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. North America Environmental Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Forensic Biotechnology: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Others: Bioinformatics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Bioinformatics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 29. North America: Bioinformatics Market, by Country, 2022 & 2028 (%)
Figure 30. US: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Bioinformatics Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America bioinformatics market.
● Highlights key business priorities to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the North America bioinformatics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the bioinformatics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – North America Bioinformatics Market

● Agilent Technologies, Inc.
● Biomax Informatics AG
● Bruker Corporation
● Dassault Systèmes
● Eurofins Scientific
● Illumina, Inc.
● PerkinElmer Inc.
● QIAGEN
● Thermo Fisher Scientific Inc.  

At 15.9% CAGR, the North America Bioinformatics Market is speculated to be worth US$ 15,559.78 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the North America bioinformatics market was valued at US$ 6,429.54 million in 2022 and is expected to reach US$ 15,559.78 million by 2028, registering an annual growth rate of 15.9% from 2022 to 2028. Increasing funding and investments in bioinformatics and increased number of genomic research activities with corresponding adoption of bioinformatics are the critical factors attributed to the market expansion.

Many private organizations and government bodies around the region are progressively investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which have developed the quality of bioinformatics services. In 2021, the US government announced an investment worth US$ 1.7 billion to enhance monitoring, detection, and mitigation of SARS-CoV-2 variants and infrastructure development for future genomic sequencing needs. Many countries are investing in their national population sequencing programs to identify the link between genetics and diseases. Government organizations are sequencing the genomes of millions of citizens to advance research and help develop better techniques to diagnose and treat cancer, rare diseases, and other conditions. Thus, the funding and investment in bioinformatics are boosting the market growth across the region.

On the contrary, lack of interoperability and multiplatform capabilities hurdles the growth of North America bioinformatics market.

Based on product, the North America bioinformatics market is segmented into knowledge management tools, bioinformatics platforms, and bio informative services. The bioinformatics platforms segment held 49.0% market share in 2022, amassing US$ 3,149.92 million. It is projected to garner US$ 7,702.37 million by 2028 to expand at 16.1% CAGR during 2022–2028. Based on application, the North America bioinformatics market is segmented into genomics, chemo informatics and drug design, proteomics, transcriptomics, metabolomics, and others. The genomics segment held 28.8% market share in 2022, amassing US$ 1,849.39 million. It is projected to garner US$ 4,517.84 million by 2028 to expand at 16.1% CAGR during 2022–2028. Based on sector, the North America bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held 26.8% market share in 2022, amassing US$ 1,723.72 million. It is projected to garner US$ 4,342.00 million by 2028 to expand at 16.6% CAGR during 2022–2028. Based on country, the North America bioinformatics market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 78.5% market share in 2022. It was assessed at US$ 5,047.54 million in 2022 and is likely to hit US$ 12,309.30 million by 2028, exhibiting a CAGR of 16.0% during the forecast period. Key players dominating the North America bioinformatics market are Agilent Technologies, Inc.; Biomax Informatics AG; Bruker Corporation; Dassault Systèmes; Eurofins Scientific; Illumina, Inc.; PerkinElmer Inc.; QIAGEN; and Thermo Fisher Scientific Inc. among others.

In Jan 2022, Thermo Fisher completed its acquisition of PeproTech on December 30, 2021, for a total cash purchase price of approximately US$ 1.85 billion. PeproTech is a privately held provider of bioscience reagents known as recombinant proteins, including cytokines and growth factors. Recombinant proteins are used in the development and manufacturing of cell and gene therapies as well as in broader cell culture applications, especially for use in cellular research models. In April 2021, Agilent Technologies, Inc. announced that it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions.